Safety and immunogenicity of an alum-adjuvanted whole-virion H7N9 influenza vaccine: a randomized, blinded, clinical trial-Reference-Cited by-同舟云学术

Safety and immunogenicity of an alum-adjuvanted whole-virion H7N9 influenza vaccine: a randomized, blinded, clinical trial

Published:2021-05 Issue:5 Volume:27 Page:775-781
ISSN:1198-743X
Container-title:Clinical Microbiology and Infection
language:en
Short-container-title:Clinical Microbiology and Infection

Author:

Wang Shilei,Xie Zhiqiang,Huang Lili,Zhou Xu,Luo Jian,Yang Yuelian,Li Changgui,Duan Peng,Xu Wenting,Chen Dandan,Wu Bing,Yang Yongli,Liu Xueying,Wang Yanxia,Yuan Zhenghong,Qu Di,Chen Ze,Xia Shengli

Funder

Shanghai Association for Science and Technology

National Key New Drug Creation and Manufacturing Program, Ministry of Science and Technology

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference29 articles.

1. Human infection with a novel avian-origin influenza A (H7N9) virus;Gao;N Engl J Med,2013

2. Avian influenza virus transmission to mammals;Herfst;Curr Top Microbiol Immunol,2014

3. Human infections with recently emerging highly pathogenic H7N9 avian influenza virus in China;Zhang;J Infect,2017

4. Effect of varying doses of a monovalent H7N9 influenza vaccine with and without AS03 and MF59 adjuvants on immune response: a randomized clinical trial;Jackson;JAMA,2015

5. Serological responses to an avian influenza A/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant: a randomized clinical trial;Mulligan;JAMA,2014

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pandemic preparedness through vaccine development for avian influenza viruses;Human Vaccines & Immunotherapeutics;2024-05-28